• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • Q&A
    • Videos
    • Comment
    • Analysis
    • People moves
    • In Profile
  •  
    Analysis
    • Videos
    • Q&A
    • Comment
    • In Profile
    • Podcast
    • Fundraising
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
UNQUOTE
  • People

ArchiMed appoints three new partners

  • Alessia Argentieri
  • Alessia Argentieri
  • 22 November 2019
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Healthcare-focused French GP ArchiMed has appointed Christophe Berthoux, Jean-Yves Desmottes and Mario Philips as partners.

Berthoux and Desmottes joined ArchiMed as operating partners, while Philips joined the firm as a strategic partner.

Prior to joining ArchiMed, Berthoux was CEO of UK-based Synexus, a provider of drug research support services and patient recruitment for clinical trials. He also worked as US-based global head of sales and marketing for Charles River Laboratories.

Berthoux will continue in his current non-executive chairman role at venture-capital-backed Imaging Analysis Group, which uses imaging technology and artificial intelligence to streamline the development of medical treatments.

Prior to joining ArchiMed, Desmottes was general manager of biology-based skincare solutions group Bioderma Dermatological Laboratories. He also served as vice-president in charge of operations at Bioderma's parent, Naos Group, and worked at PwC, where he advised on mergers, acquisitions and restructurings in the healthcare sector.

Philips is the non-executive chairman of ArchiMed portfolio company Clean Biologics, a specialist in safety testing for biopharmaceuticals. In March, he also became CEO of PolyneuroS, a developer of kits for the diagnosis and follow-up treatment of neurodegenerative conditions. As a strategic partner at ArchiMed, he will continue in his positions at both PolyneuroS and Clean Biologics.

ArchiMed is a private equity firm targeting companies based in Europe and North America, and operating in the biopharma, medtech, diagnostics, life sciences, healthcare IT, consumer health, public safety and care services sectors. Its international team combines investment, medical, technological and operational experience.

The firm is currently investing via its Med II fund, which closed on €315m in September 2017. The vehicle deploys equity tickets in the €5-50m range.

ArchiMed recently exited Italian dental group Primo, which was a portfolio company of its Med I fund, reaping a 3x return on the investment.

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • People
  • GPs
  • Healthcare
  • France
  • Archimed
  • people moves
  • France

More on People

CapMan Managing Partner Johan Pålsson to depart
CapMan Managing Partner Johan Pålsson to depart

PУЅlsson resigns from management effective immediately; to stay as buyout partner until February 2024

  • People
  • 11 August 2023
​​​​​Capvis grapples with EUR 1bn fundraise amid team exodus
​​​​​Capvis grapples with EUR 1bn fundraise amid team exodus

Five partners for the Swiss-based GP leave firm in last two years; sponsor started sixth buyout fundraise in early 2023

  • People
  • 11 August 2023
Golding adds insurance expertise with hire for institutional clients team
Golding adds insurance expertise with hire for institutional clients team

Tim Ickenroth joins as director with prior experience at BNP Paribas and UniCredit

  • People
  • 11 August 2023
Travers Smith bolsters funds practice with hire from Proskauer
Travers Smith bolsters funds practice with hire from Proskauer

Tosin Adeyeri joins with particular experience in secondary portfolio transactions

  • People
  • 03 August 2023

Latest News

Partners Group to release IMs for Civica sale in mid-September
  • Exits
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
BHM Group builds on PE strategy, eyes European medtech and renewable energy acquisitions
  • Investments
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Czech Republic-headquartered family office is targeting DACH and CEE region deals

  • 01 September 2023
Redalpine expands leadership team amid CHF 1bn-plus fundraise
  • Venture
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO

  • 31 August 2023
Change Ventures aims to hold final close for EUR 20m third fund by mid-2024
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds

  • 31 August 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013